Anaerobes outnumber aerobic bacteria in the human gut. The most commonly isolated microorganisms in intra-abdominal infections include Escherichia coli, Peptostreptococcus micros as well as Bacteroides and Clostridium species. Several studies have been undertaken on southern African medicinal plant species and their antimicrobial efficacy against pathogens such as E. coli that cause stomach ailments. However, pathogens such as Helicobacter pylori, Fusobacterium varium as well as others have been neglected in medicinal plant antimicrobial research. The aim of this study was to evaluate the antimicrobial activity of selected medicinal plants documented for stomach ailments against neglected gut pathogens. A total of 102 aqueous and organic extracts were prepared from 40 different plant species. These plant samples were screened for antimicrobial efficacy against eight anaerobes and two microaerophilic strains using the micro-dilution antimicrobial assay. Plant extracts that displayed noteworthy antimicrobial activity against Clostridium perfringens were further evaluated for antibiofilm activity using the crystal violet staining assay. The toxicity profiles of plants that displayed noteworthy antimicrobial activity were evaluated using the brine shrimp lethality assay which revealed that most of the tested plant samples were non-toxic in nature, and the aqueous extracts proved to be safer. The organic extract of Lippia javanica leaf showed the best antimicrobial activity with a minimum inhibitory concentration of 0.5 µg/mL against C. perfringens. The organic extract of Salvia africana-caerulea displayed the best antibiofilm activity overall, at cell attachment (4 h) biofilm developmental stage with inhibition percentages of 82.8%.
Introduction
Intra-abdominal infections are infections of the stomach and are a substantial cause of mortality and morbidity. 1, 2 Intra-abdominal inflictions include peritonitis, intra-abdominal abscesses, appendicitis, colorectal cancer, ulcerative colitis, food poisoning, chronic atrophic gastritis, peptic ulceration and stomach cancer. [3] [4] [5] Pathogens associated with intra-abdominal infections include Escherichia coli, the Bacteroides fragilis group, and Clostridium species. 6, 7 Bacteroides species are opportunistic bacteria that form part of the normal microbiota and are often associated with polymicrobial infections such as intra-abdominal, pelvic, genital, complicated skin and soft tissue, and bloodstream infections. 6, [8] [9] [10] Clostridium species are associated with pseudomembranous colitis which is triggered by the intake of broad-spectrum antibiotic therapy and may be the cause of infectious diarrhoea in hospital patients. 11 Other pathogens that are isolated in intra-abdominal infections include Helicobacter pylori as well as Fusobacterium species. 3, 5, 12 Helicobacter pylori infects more than 50% of the world's population; however, only a small percentage of patients develop severe disorders. 13 People that are most likely to be infected are from developing countries. 14 Another bacterial species that is associated with cancer of the gut is Fusobacterium spp. These species are associated with severe infections and are often related to colorectal cancer, which is the third most common cancer worldwide. 12, 15 A wide range of antibiotics and treatment regimens are used for the treatment of intra-abdominal infections. Increased antibiotic resistance is the main cause of treatment failure. 9, 16 Phytomedicine has proved to be an alternative treatment for different diseases, including gastrointestinal disorders. 14, [17] [18] [19] The use of the medicinal plants selected for this study have previously been reported; however, the scientific evidence for their activity against neglected pathogens of the gut has not been adequately explored.
Globally, some antimicrobial studies have focused on evaluating the activity of traditional medicinal plants against neglected gut pathogens and have shown promising antimicrobial activities against fastidious gut pathogens. 14, 20, 21 In southern Africa, several studies have focused on evaluating the antimicrobial efficacy of medicinal plants against commonly studied gut pathogens such as Staphylococcus aureus, Shigella flexineri, E. coli, Enterococcus faecalis and Candida albicans. 22 A review from a period dating almost 20 years demonstrated that very few, if any, southern African medicinal plant studies are related to gut anaerobes. 22, 23 Most plant-based antimicrobial studies have focused on planktonic microorganisms, although many of the fastidious pathogens selected for this study occur not only in planktonic form but also as biofilms. Biofilms are defined as multicellular matrices of bacteria surrounded by an extracellular polysaccharide called a glycocalyx. 24 The ability of bacteria to aggregate and form biofilms makes it difficult to treat bacterial infections as biofilms enhance the bacteria's ability to resist the host's immune system response, thus contributing to the development of antibiotic resistance. 25, 26 As far as we could ascertain, no previous study has focused on the antibiofilm activity of medicinal plants against C. perfringens and thus, this warranted attention.
Furthermore, plants commonly used in traditional medicine are often believed to be non-toxic. However, scientific research has shown that many of them can be lethal, mutagenic and carcinogenic. 27, 28 Thus the aim of this study was to evaluate the antimicrobial activity of selected medicinal plants documented for stomach ailments against neglected gut pathogens responsible for intra-abdominal infections and to further investigate biofilm activity (using C. perfringens as a model) and toxicity profiles of plants that demonstrated noteworthy antimicrobial activities.
Materials and methods

Ethnobotanical review, plant identification and collection
An ethnobotanical literature review was conducted to identify the southern African medicinal plants used traditionally to treat stomach ailments (Table 1) . Several medicinal plant based books and scientific databases were used to search for plants that are used traditionally to treat stomach ailments. 29, [30] [31] [32] [33] Approximately 155 medicinal plant species were identified. From these, medicinal plant species which could be successfully collected from various botanical gardens (with respect to cost, season, accessibility, sustainability and time) were selected for the study. The selected plant species were collected from the Walter Sisulu National Botanical Garden (Roodepoort, Gauteng, South Africa), where the chief horticulturist, Mr Andrew Hankey, granted permission and assisted in plant identification. All documents for the transfer of materials for research purposes were completed accordingly. Medicinal plant material that was not available at Walter Sisulu National Botanical Garden was purchased from Random Harvest Indigenous Nursery (Muldersdrift, Gauteng, South Africa). Following collection, voucher specimens were prepared for each species and were housed in the Department of Pharmacy and Pharmacology, University of the Witwatersrand.
The collected plant samples were left to dry at room temperature. Once completely dried, samples were separated into different plant parts, i.e. roots, leaf, fruits, bark and stems. Dried plant materials were then crushed to powder using the high-speed Fritsch Pulverisette grinder (Labotec, Johannesburg, South Africa) or using a hand-held pounder (purchased at Faraday supermarkets) for harder stems and barks.
Preparation of plant extracts
Plant powder was resuspended in 1:1 dichloromethane:methanol (Sigma-Aldrich, Johannesburg, South Africa) at a ratio of plant powder:solvent of 1:2, and then placed in the platform shaker incubator (Labcon, Johannesburg, South Africa) at 37 °C for 24 h. Thereafter, the solvent was filtered and left in a fume hood to evaporate. The samples were extracted again with fresh solvent for another 24 h. Once the solvent had evaporated, the extract was transferred into suitable amber bottles for storage at ambient temperature. Aqueous extracts were prepared by immersing plant powder material in sterile distilled water. This immersion was followed by incubation in platform shaker incubator, overnight at 30 °C. Thereafter, the liquid extracts were strained and stored at -80 °C for 24 h before lyophilisation. Aqueous extracts were lyophilised using a freeze dryer (Virtis, South Africa) for approximately 7 h or overnight. Before use, aqueous extracts were placed under ultraviolet light overnight to eliminate possible microbial contaminants. All plant samples were stored in appropriate containers at room temperature. Table 1 details the plant species collected, common names, reported traditional use, plant part used and percentage yield.
Plant sample preparation
Samples were prepared by weighing out the crude extracts and calculating the volume of solvent to be added to create a sample concentration of 32 mg/mL. Acetone (Sigma-Aldrich) was used as the solvent of choice for organic samples as it has minimal antimicrobial effects. Sterile water was used to dissolve aqueous extracts. 
Test microorganisms
Test pathogens were selected according to their propensity to cause stomach ailments. Most of the selected microorganisms were obtained from the American Type Culture Collection (ATCC) and were purchased from Davies Diagnostics (Johannesburg, South Africa). Eight members of the Gram-negative anaerobic bacilli were selected. Two non-fastidious pathogens, E. coli (ATCC 8739) and E. faecalis (ATCC 29212), were included as comparators of activity (Table 2 ). These microorganisms were cultured in the respective media and under the incubation conditions prescribed by the Clinical Laboratory Standards Institute 34 , with slight modifications as described in Table 2 . Two ethics waivers for the use of these microorganisms were obtained from the University of the Witwatersrand Human Research Ethics Committee (reference no. W-CBP-180509-01 for anaerobes and aerobic bacteria; and M170582 for H. pylori strains).
For H. pylori, the clinical strain was obtained from Chris Hani Baragwanath Academic Hospital (Johannesburg, South Africa). Methods as previously described 35 were used to isolate the strains from patients. This isolation was achieved by obtaining biopsies from the antrum and corpus. These specimens were then placed in sterile bijou bottles containing a mixture of cysteine (200 mg/mL) and glycerol (20%) in brain heart infusion broth and transported on ice to the laboratory within 2 h of collection. Helicobacter pylori isolates were then confirmed by: polymerase chain reaction using glmM as the target gene; colony morphology and characteristic spiral morphology on Gram staining; and positive catalase, urease and oxidase tests. Confirmed isolates were suspended in 20% glycerol and stored at -80 °C in a freezer for future use. A reference strain, namely H. pylori (B8), was also tested. This strain was obtained from the Ludwig Maximilian University of Munich (Germany) medical microbiology laboratory, through the University of the Witwatersrand's Department of Surgery.
Antimicrobial analysis
Antimicrobial susceptibility was evaluated using the minimum inhibitory concentration (MIC) assay with specific modifications to facilitate fastidious growth of pathogens. 34, 36 Using aseptic techniques, 100 μL of broth, selected depending on the microorganism being tested, was introduced to all wells of the 96-well microtitre plates. Thereafter, 100 μL of respective plant sample to be tested was placed in the top row of the microtitre plate.
Controls (positive, negative and culture) were included in all assays. The role of the negative control was to ensure that the solvent (acetone) exerted no or minimal antimicrobial effect. Positive controls at starting concentrations of 0.01 mg/mL were used to validate the microbial susceptibility: ciprofloxacin was used for E. coli, E. faecalis, C. perfringens and Fusobacterium species; an equal ratio mix of clarithromycin and amoxicillin was used for H. pylori species; imipenem for Bacteroides species; and metronidazole for C. difficile. Ciprofloxacin was used as a broad-spectrum antibiotic. Metronidazole, imipenem, clarithromycin and amoxicillin were selected based on their antimicrobial susceptibility. A culture control was added to 
Antibiofilm analysis
Plant extracts that exhibited noteworthy activity (MIC≤160 μg/mL) against C. perfringens were selected for biofilm studies. Clostridium perfringens was also selected because it was the most susceptible of all the pathogens studied. Plant samples were immersed in sterile water and thereafter sonicated at room temperature and low speed using ultrasonic waves (SCIENTECH). The effect of plant extracts on biofilm attachment was tested using the method described by Sandasi et al. 37 Using spectrophotometric methods, microbial cultures containing approximately 1x10 6 CFU/mL were prepared and added to the wells of a new 96-well microtitre plate, and a blank column containing sterile broth was also included. Prior to testing, the plate was incubated anaerobically for 4 h at 37 °C.
To test for the effect of plant extracts on established biofilms, the method described above was used, except stock cultures were incubated for 24 h, 48 h and 72 h at 37 °C. After incubation, 100 μL of each plant extract was transferred to a final concentration of 1 mg/mL in the wells. Plates were incubated overnight at 37 °C, after which the crystal violet assay was performed at selected time intervals and the biofilm biomass determined. The percentage inhibition was calculated using Equation 1 37 :
The crystal violet assay was undertaken to evaluate the ability of the extracts to prevent and inhibit the development of biofilms. This was done by washing the incubated plates with sterile water and oven drying them at 60 °C for 45 min. Once dried, all the wells were stained with 200 μL of 1% crystal violet and left at room temperature for 15 min to allow for proper absorption of the stain. This was followed by washing the plates with sterile water three times to remove the unabsorbed stain and adding 125 μL ethanol as a de-staining solution. A volume of 100 μL of the de-staining solution was transferred to a new microtitre plate and the absorbance was determined at 590 nm using a microplate reader (Universal microplate reader ELX 800). The mean absorbance of the extracts was determined prior to calculating the percentage inhibition. All tests were repeated at least in triplicate for reproducibility. 
Toxicity of plant extracts
In order to hatch brine shrimp larvae, artificial seawater was prepared by dissolving 16 g of Tropic Marine ® salt in 500 mL sterile water. Thereafter, 0.5 g of brine shrimp larvae (Artemia franciscana) (Ocean Nutrition) was added to the prepared seawater. Seawater was selected because it promotes the growth of brine shrimp larvae. A mixture containing the brine shrimp larvae and seawater was exposed to constant light from a light emitting diode (LED) bulb. Then larvae were aerated using a rotary pump (Kiho) to promote a better hatch. The mixture was then left at room temperature (25 °C) for 1-2 days. Toxicity was investigated for all extracts that displayed noteworthy antimicrobial activities (MIC≤160 μg/mL) against any of the tested pathogens (Table 3 ). Both the dichloromethane:methanol and aqueous plant extracts were prepared to a stock concentration of 2 mg/mL, and then a starting concentration of 1 mg/mL was achieved after dilution. Organic extracts were dissolved in 2% v/v dimethyl sulfoxide and aqueous extracts were dissolved in sterile water.
Hatched shrimp were transferred into a shallow, four-sided container, and then the LED study lamp was placed next to the container facing the opening of the container. This placement allowed for maximum light exposure, which in turn allowed the shrimp to gather in one place for easy collection. 
Results and discussion
Antimicrobial analysis
The results of the antimicrobial assay expressed as MIC values are represented in Table 3 . Antimicrobial activity was considered noteworthy for plant extracts when MIC values were ≤160 μg/mL. Moderate values were between 160 μg/mL and 1000 μg/mL and weak activity was classified as MICs of >1000 μg/mL. Poor activity is expressed by MICs greater than 8000 μg/mL. 22, 39, 40 For the aqueous extracts, G. perpensa (leaf and rhizome) was the most active with a MIC of 130 μg/mL against the Clostridium species. As the organic extracts showed better activity, only these results are presented in Table 3 .
Antimicrobial activity was compared for leaf and other plant parts; 7 of the 10 plants evaluated (70%) showed better activity for leaves than for other plant parts. Interestingly, none of the plant extracts displayed noteworthy antimicrobial activity against the common gut pathogens E. coli and E. faecalis.
Antimicrobial activity against Gram-positive bacteria
Gram-positive bacteria included two Clostridium species: C. perfringens and C. difficile. The Gram-positive bacteria were more vulnerable to the extracts than were the Gram-negative bacteria. Clostridium perfringens was the most susceptible. Approximately 10% of the extracts displayed noteworthy antimicrobial activity against C. difficile, whereas 39% of the extracts displayed moderate activity. Approximately 39% of the extracts displayed noteworthy activity against C. perfringens and another 39% displayed moderate activity.
The organic extracts of L. javanica leaf showed the best antimicrobial activity with an MIC of 0.5 μg/mL against C. perfringens. This value was comparable to the control antibiotic ciprofloxacin (MIC=0.2 μg/mL). The traditional use of L. javanica corroborates with the antimicrobial activity against Clostridium species, as the leaf infusion is traditionally used to treat diarrhoea, which is one of the symptoms of food poisoning or pseudomembranous colitis. 41 Even though L. javanica displayed the best antimicrobial activity, to the best of our knowledge, this plant species has not been tested previously against Clostridium species.
Other studies have instead focused on the antimicrobial activity of this plant species against common pathogens such as S. aureus, E. coli, E. faecalis, and Pseudomonas aeuruginosa. 42 Negative control >8000 >8000 >8000 >8000 >8000 >8000 >8000 >8000 >8000 >8000 >8000 >8000
Culture control >8000 >8000 >8000 >8000 >8000 >8000 >8000 >8000 >8000 >8000 >8000 >8000 C. d: C. difficile (ATCC 43593); C. p: C. perfringens (ATCC 13124); B. f: B. fragilis (ATCC 23745); B. o: B. ovatus (ATCC 8483); B. t: B. thetaiotaomicron (ATCC 29741); B. v 30 To date, no previous studies have reported on the antimicrobial effectiveness of this plant on neglected pathogens. Nevertheless, findings from the current study were comparable to those reported in the literature, that is, Madikizela et al. 43 reported good activity for the organic extracts of G. perpensa (leaf) against the gut pathogens Campylobacter jejuni, E. coli, S. aureus and Shigella flexineri, with MICs between 0.39 mg/mL and 0.78 mg/mL.
Traditionally, twig and leaf infusions of S. africana-caerulea are mixed with Epsom salts (magnesium sulfate) and lemon to treat stomach illnesses such as colic, diarrhoea, indigestion and stomach pain. 30 To the best of our knowledge, no antimicrobial study was found with regard to S. africana-caerulea and the gut pathogens selected for this study. However, several other studies have reported on the antimicrobial activity of S. africana-caerulea against other gut microorganisms. 44 Spirostachys africana is commonly known as the jumping-bean tree and it is traditionally used for the treatment of stomach ulcers, stomach pain, dysentery, acute gastritis and diarrhoea. 31 The antimicrobial effects of S. africana on other pathogens has also been reported, 45 with leaf and twig extracts showing good activity against S. aureus at a mean MIC value of 0.78 mg/mL.
The antimicrobial activity of S. cordatum validates the traditional use as the bark is boiled in water, then the mixture is taken orally three times a day until diarrhoea resolves. 30 Mathabe et al. 31 reported S. cordatum to be effective against a wide variation of diarrhoeal pathogens, including S. aureus, E. coli, S. typhimurium, Vibrio cholerae as well as Shigella species, with MIC values in the range of 0.16-0.31 mg/mL.
In previous studies, T. riparia showed good antimicrobial activity against common pathogens of the gut. 28, 44 Tetradenia riparia is a multi-branched shrub or small tree, the leaves of which are traditionally used in infusions to treat stomach aches and diarrhoea. 30 No study was found on the antimicrobial activity of T. riparia against Clostridium species. In a previous study 44 , T. riparia was found to be active against S. aureus with an MIC value of 0.78 mg/mL. Good antimicrobial activity of T. riparia was also noted against oral pathogens. 28 Other extracts that displayed noteworthy activity against C. perfringens include Acokanthera oppositifolia (MIC=130 μg/mL), Aloe arborescens (MIC=30 μg/mL), Aloe marlothii (MIC=130 μg/mL), Aloe tenuior (MIC=2 μg/mL), Antidesma venosum (MIC=60 μg/mL), Artemisia afra (MIC=8 μg/mL), Bridelia micrantha (MIC=130 μg/mL), Polygala fruticosa (MIC=20 μg/mL), Solanum incanum (MIC=130 μg/mL) and S. cordatum (MIC=130 μg/mL).
Antimicrobial activity of organic extracts against Gramnegative bacteria
Gram-negative bacteria included eight bacterial groups which were further divided into two classes': (1) B. fragilis, B. ovatus, B. thetaiotaomicron,  B . vulgatus, F. nucleatum and F. varium and (2) Gram-negative microaerophiles (H. pylori reference and the clinical strain). 
Gram-negative anaerobes
Gram-negative microaerophiles
Microaerophiles included the Helicobacter spp. which are a group of microorganisms that require a lower concentration of oxygen to survive. 46, 47 The organic extracts of A. arborescens displayed the best antimicrobial activity with an MIC value of 130 μg/mL against the reference strain. Comparative studies regarding anti-Helicobacter activities of A. arborescens were not found in the literature; however, it is not surprising that this species displayed good antimicrobial activity against H. pylori, because a decoction of the fresh leaves of Aloe species is traditionally used for management of H. pylori related infections. 18
Antibiofilm assay
Results for the antibiofilm activities are categorised into four phases corresponding to biofilm developmental stages. First, the initial attachment of biofilms is represented at 4 h; biofilm formation at 24 h; and development of a mature biofilm at 48 h and 72 h. The results are presented in Table 4 and are interpreted either as weak antibiofilm activity (0-49%) or good antibiofilm activity (50-100%). 48 (Table 3) , it is very interesting to note that the L. javanica extract was not only active against planktonic cells of C. perfringens but also displayed activity at an additional three biofilm developmental stages.
These results support a previous study in which it was found that the same plant extracts that had good antibacterial activity also had good antibiofilm activity. 48 The organic extracts of S. This study is the first to report on the antibiofilm activity of plant extracts on C. perfringens biofilms. Globally, most plant-based studies have focused on the antibiofilm activity of medicinal plants against biofilm formers such as E. coli, S. aureus and P. aeruginosa. 49, 50 For southern African plant species, studies undertaken on antibiofilm activity have been neglected. Only a few relevant studies have been investigated. 22 Most of these have focused on the antibiofilm activities of southern African medicinal plants against clinically important pathogens such as Listeria monocytogenes, P. aeruginosa and C. albicans. [48] [49] [50] [51] [52] The antibiofilm activity of southern African medicinal plants has been investigated against the oral pathogen Streptococcus mutans. 28 The current study showed that some plant extracts that showed good antimicrobial activity against C. perfringens in the MIC assay are capable of inhibiting C. perfringens biofilms. Prevention of cell attachment proved to be more difficult to achieve than prevention of biofilm development in a mature biofilm. It is very surprising that many extracts displayed better activity at biofilm development stage (24 h) than at cell attachment stage (4 h), as a previous study reported that inhibiting initial cell attachment is easier than inhibiting preformed biofilms. 47
Toxicity assay
The 22 medicinal plant extracts that displayed noteworthy antimicrobial activity (MIC ≤160 μg/mL) ( Table 3) against neglected gut pathogens, were screened for toxicity. The results of the brine shrimp lethality assay for both organic and aqueous extracts are shown in Values marked in bold denote mortality greater than 50% and are considered toxic. Table 7 displays a complete overview of the plant extracts that were active against at least one pathogen, displayed good antibiofilm activity at one biofilm development stage and had low cytotoxic effect. These plant species warrant further investigation.
Conclusion
The results from the MIC assay favour the traditional use of some plant extracts for intra-abdominal infections. The Gunnera perpensa organic extract was the most interesting of all the tested extracts, in that it displayed very good antimicrobial activity against Clostridium species (MIC = 2-130 µg/mL). The plant species also displayed good antibiofilm activity against new and older biofilms (average inhibition = 52.3% for leaf extract and 58.7% for rhizome), with no toxic effects (mortality = 0%). A notable result was seen in the aqueous extracts of G. perpensa (leaf and rhizomes), where noteworthy activity was observed against Clostridium species with MIC values of 130 μg/mL. In some instances, there was a direct relationship between the antimicrobial activity and the traditional use. For example, S. africana is traditionally used for diarrhoea.
In the current study the organic extract of the leaf displayed noteworthy activity against C. difficile and C. perfringens. Also interesting is that none of the plant extracts displayed noteworthy activity against the common pathogens E. coli and E. faecalis. Biofilm results indicated that most of the plants that were active against C. perfringens were also effective against C. perfringens biofilms. The brine shrimp lethality assay results revealed that most of the plant samples were non-toxic to the brine shrimps. This study demonstrates that investigations should not only focus on common pathogens, but also on neglected pathogens which may yield excellent results not previously reported. This study contributes to the knowledge of the antimicrobial properties of plants commonly found in southern Africa. 
